Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Sebastian Unizony MD

Sebastian Unizony MD

Assistant Professor of Medicine, Harvard Medical School; Co-Founder and Co-Director, Massachusetts General Hospital Vasculitis and Glomerulonephritis Center, Boston, Massachusetts

Dr. Sebastian Unizony is an Assistant Professor in Medicine at Harvard Medical School. He is the Co-Founder and Co-Director of the Massachusetts General Hospital Vasculitis and Glomerulonephritis Center. His research interests are in clinical outcomes, biomarkers, and novel therapies in vasculitis, especially giant cell arteritis and ANCA-associated vasculitis. Dr. Unizony is a clinical investigator in multiple national and international collaborative endeavors in the field of vasculitis. His work has resulted in numerous publications (https://connects.catalyst.harvard.edu/Profiles/display/Person/86464).

Disclosures

Dr. Unizony reports the following:
  • Genentech, research support
  • Novartis, research support
  • Janssen, consulting and research support
  • Kiniksa, consulting

Recent Contributions to PracticeUpdate:

  1. Efficacy and Safety of TNF-α Antagonists and Tocilizumab in Takayasu Arteritis

Recently Updated